SS&C Intralinks Success Stories

We’ve helped clients in nearly every country and industry throughout the world with secure innovative, productivity-driving solutions for high-value M&A, debt capital markets and banking transactions.

Here are just a few of our recent success stories. We’d love to add your brand to our hall of fame.

True Capital III​

£$275 million​

True Capital III​
True Capital seeks to invest in UK-headquartered, lower-mid market businesses operating in the consumer products and services sector.​
Sofinnova Capital X​

€472 million​

Sofinnova Capital X​
Sofinnova Capital X is a venture capital fund investing into in early-stage healthcare companies in the biopharmaceutical and medical device industries in Europe.​
Singular​

€225 million​

Singular​
Singular is an early stage fund investing in European companies operating within a diversified range of sectors..​
Redpoint Omega IV​

€455 million​

Redpoint Omega IV​
Oakley Capital Origin is a fund managed by Oakley Capital Private Equity. The fund invests in a wide range of industries​
Providence Strategic Growth Europe​

€1.25 billion​

Providence Strategic Growth Europe​
Providence Strategic Growth Europe seeks investments in lower middle market software and technology-enabled service companies. The fund will invest 90-95% in Western Europe.​
Oriens Capital Private Equity Fund 2​

$100 million​

Oriens Capital Private Equity Fund 2​
Oriens Capital Private Equity Fund 2 is the second fund in its series. The fund focuses on mid-market opportunities in regional New Zealand. ​
Naxicap Investment Opportunities II​

€856 million​

Naxicap Investment Opportunities II​
Naxicap Investment Opportunities II invests in SMEs that show high internal, or build-up growth potential, in both France and Europe.​
Mill Reef Capital Fund SCS​

€180 million​

Mill Reef Capital Fund SCS​
Mill Reef Capital Fund SCS is a secondaries fund advised by Mill Reef Capital and targets investment opportunities across Europe.​
mcp Opportunity Secondary Program Fund V​

€1.3 billion​

mcp Opportunity Secondary Program Fund V​
mcp Opportunity Secondary Program Fund V is the fifth vehicle raised by Montana Capital Partners and will follow a similar strategy to its predecessors, by completing small and more complex secondary transactions.​
Idekapital Fund 2​

kr914 million​

Idekapital Fund 2​
Idekapital Fund II is a fund managed by Idekapital which invests on growing Norwegian technology companies.​

€2 billion​

GHO Capital III​
GHO Capital Fund III is the firm's third buyout vehicle that focuses on mid-market buyout and growth opportunities in the healthcare sector. ​
Eurazeo Growth III​

$1.89 billion​

Eurazeo Growth III​
Eurazeo Growth Fund III will assist fast-growing companies in technology sectors by setting up the necessary financial and human resources for their development and the completion of transformation projects.​
Digital Health 2​

€155 million​

Digital Health 2​
Digital Health 2 is a venture capital vehicle that targets SMEs in commercial phase operating in the digital health industry.​
Development Partners International

$900 million​

African Development Partners III
African Development Partners III is the firm's third growth fund dedicated to investments in companies serving Africa's middle class. ​
NEX Group

£4.1 billion

NEX Group
NEX Group, a listed UK-based provider of electronic financial trade execution platforms, transaction lifecycle management and information services, used Intralinks for its acquisition by CME Group for £4.1 billion.

EUR€650 million

EMH Growth Fund II invests growth capital in technology-enabled companies in Europe.
Zodiac Aerospace

€8.3 billion

Zodiac Aerospace
Zodiac Aerospace, a listed France-based manufacturer of aerospace equipment and systems, used Intralinks for its acquisition by Safran for €8.3 billion.
Holland & Barrett Retail

£1.8 billion

Holland & Barrett Retail
Holland & Barrett Retail, Europe’s largest health and wellness retailer, used Intralinks for its acquisition by L1 Retail from The Carlyle Group for £1.8 billion.